ciprofloxacin has been researched along with cyclosporine in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (24.24) | 18.2507 |
2000's | 9 (27.27) | 29.6817 |
2010's | 15 (45.45) | 24.3611 |
2020's | 1 (3.03) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
Avdeef, A; Tam, KY | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bouillon, A; Cresteil, T; Fontaine, F; Héquet, A; Jolivalt, C; Lesnard, A; Rault, S; Voisin-Chiret, AS | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Bause, H; Höver, S; Scholz, J; Schulz, M; Steinfath, M | 1 |
Ekberg, H; Forsgren, A; Ostraat, O; Riesbeck, K; Schatz, H; Tufveson, G | 1 |
Ekberg, H; Forsgren, A; Riesbeck, K | 1 |
Hoey, LL; Lake, KD | 1 |
Forsgren, A; Gullberg, M; Riesbeck, K | 1 |
Keown, PA; Kim, S; Landsberg, D; Levine, M; Lewis, S; Partovi, N; Primmett, DR; Wrishko, RE | 1 |
Pons, G; Rey, E; Tréluyer, JM | 1 |
Bernstein, RM | 1 |
Inman, RD; Stone, M | 1 |
Bell, H; Parslew, R | 1 |
Droogh, JM; Fieren, MW; Gyssens, IC; Van Gelder, T; Van Zonneveld, M; Weimar, W | 1 |
Borrás-Blasco, J; Conesa-García, V; Gomez-Corrons, A; González-Delgado, M; Marín-Jiménez, F; Navarro-Ruiz, A | 1 |
Bressler, B; Sands, BE | 1 |
Bermejo, M; Casabó-Alós, VG; Fernández-Teruel, C; Garrigues, TM; González-Alvarez, I; Polli, JE; Ruiz-García, A | 1 |
Boehler, A; Rechsteiner, T; Remund, K; Rentsch, K; Russi, EW; Vogt, P | 1 |
Balbir-Gurman, A; Bergman, R; Braun-Moscovici, Y; Egozi, D; Markovits, D; Melamed, Y; Ramon, Y; Rozin, AP; Schapira, D; Toledano, K; Ullman, Y | 1 |
Milanova, A; Petkova, T; Poźniak, B | 1 |
7 review(s) available for ciprofloxacin and cyclosporine
Article | Year |
---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Does ciprofloxacin interact with cyclosporine?
Topics: Ciprofloxacin; Clinical Trials as Topic; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Humans; Kidney Diseases | 1994 |
Drug disposition in cystic fibrosis.
Topics: Absorption; Anti-Infective Agents; Ciprofloxacin; Cloxacillin; Cyclosporine; Cystic Fibrosis; Fleroxacin; Humans; Theophylline; Tissue Distribution | 1998 |
Drugs and toxins: fact and fancy.
Topics: Anti-Infective Agents; Ciprofloxacin; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosuppressive Agents; Silicones; Toxins, Biological | 1999 |
Recent developments in the therapy of spondyloarthropathies.
Topics: Alleles; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Reactive; Chronic Disease; Ciprofloxacin; Cyclosporine; Double-Blind Method; Drug Combinations; Follow-Up Studies; Forecasting; Glucosamine; Humans; Immunosuppressive Agents; Lymecycline; Meta-Analysis as Topic; Methotrexate; Multicenter Studies as Topic; Placebos; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Spondylarthropathies; Sulfasalazine; Time Factors; Tumor Necrosis Factor-alpha | 2000 |
Review article: Medical therapy for fistulizing Crohn's disease.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Ciprofloxacin; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Metronidazole | 2006 |
26 other study(ies) available for ciprofloxacin and cyclosporine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Boronic Acids; Ciprofloxacin; Humans; KB Cells; Multidrug Resistance-Associated Proteins; Pyridines; Staphylococcal Infections; Staphylococcus aureus | 2015 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Fluconazole is removed by continuous venovenous hemofiltration in a liver transplant patient.
Topics: Anuria; Candidiasis; Ciprofloxacin; Cyclosporine; Fluconazole; Hemofiltration; Humans; Liver Transplantation; Male; Middle Aged; Vancomycin | 1995 |
Enhancement of the immunosuppressive effect of cyclosporin A by ciprofloxacin in a rat cardiac allograft transplantation model.
Topics: Animals; Cells, Cultured; Ciprofloxacin; Cyclosporine; Drug Synergism; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Interleukin-2; Lymphocytes; Mice; Rats; Rats, Inbred BN; Rats, Wistar; Transplantation, Homologous; Up-Regulation | 1995 |
Ciprofloxacin interferes with the immunosuppressive effects of cyclosporin A on cytokine production in vitro.
Topics: Cells, Cultured; Ciprofloxacin; Cyclosporine; Cytokines; Dose-Response Relationship, Drug; Gene Expression; Humans; Immunosuppression Therapy; Interferon-gamma; Interleukin-2; Kinetics; Lymphocytes; RNA, Messenger | 1994 |
Evidence that the antibiotic ciprofloxacin counteracts cyclosporine-dependent suppression of cytokine production.
Topics: Blotting, Northern; Cells, Cultured; Ciprofloxacin; Cyclosporine; DNA Probes; Drug Combinations; Humans; Interferon-gamma; Interleukin-2; Lectins; Lymphocyte Activation; Lymphocytes; RNA, Messenger | 1994 |
Investigation of a possible interaction between ciprofloxacin and cyclosporine in renal transplant patients.
Topics: Anti-Infective Agents; Biopsy; Case-Control Studies; Chi-Square Distribution; Ciprofloxacin; Cyclosporine; Drug Interactions; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Reoperation; Retrospective Studies | 1997 |
Pyoderma gangrenosum in childhood--the importance of early recognition.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Child, Preschool; Ciprofloxacin; Cyclosporine; Dermatologic Agents; Female; Humans; Prednisolone; Pyoderma Gangrenosum | 2002 |
Yersinia pseudotuberculosis bacteraemia in a kidney transplant patient.
Topics: Anti-Infective Agents; Bacteremia; Ciprofloxacin; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Retreatment; Splenic Diseases; Tomography, X-Ray Computed; Yersinia pseudotuberculosis Infections | 2002 |
Ciprofloxacin, but not levofloxacin, affects cyclosporine blood levels in a patient with pure red blood cell aplasia.
Topics: Adult; Ciprofloxacin; Cyclosporine; Humans; Levofloxacin; Male; Ofloxacin; Red-Cell Aplasia, Pure | 2005 |
In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results.
Topics: Algorithms; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Ciprofloxacin; Colon; Cyclosporine; Dose-Response Relationship, Drug; Fluoroquinolones; Immunosuppressive Agents; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Kinetics; Male; Models, Biological; Molecular Structure; Muscarinic Antagonists; p-Aminohippuric Acid; Permeability; Quinidine; Rats; Rats, Wistar; Vasodilator Agents; Verapamil | 2007 |
Attenuation of airway obliteration by ciprofloxacin in experimental posttransplant bronchiolitis obliterans.
Topics: Animals; Bronchiolitis Obliterans; Ciprofloxacin; Cyclosporine; Immunosuppressive Agents; Male; Postoperative Complications; Rats; Rats, Inbred BN; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA; Trachea; Transplantation, Heterotopic; Transplantation, Homologous | 2008 |
Large leg ulcers due to autoimmune diseases.
Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Azathioprine; Ciprofloxacin; Cyclophosphamide; Cyclosporine; Female; Humans; Hydroxychloroquine; Hyperbaric Oxygenation; Infliximab; Larva; Leg Ulcer; Male; Methylprednisolone; Middle Aged; Prednisolone; Skin Transplantation; Treatment Outcome; Vancomycin; Vasculitis; Young Adult | 2011 |
The effects of cyclosporine A or activated charcoal co-administration on the pharmacokinetics of enrofloxacin in chickens.
Topics: Animals; Charcoal; Chickens; Chromatography, Liquid; Ciprofloxacin; Cyclosporine; Enrofloxacin; Fluoroquinolones; Tandem Mass Spectrometry | 2023 |